BROWNSTEIN HYATT FARBER SCHRECK, LLP for FERRING PHARMACEUTICALS INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to microbiome, oncology, fertility, and health equity. Issues related to formulary tier status. NDAA FY25
Foreign entity interest: Ferring Holdings SA and Ferring BV listed on the registration under foreign entities have an interest in health equity.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRANDT ANDERSON | — |
| WILLIAM DUNHAM | — |
| EMILY FELDER | — |
| ADAM STEINMETZ | — |
| DEEMA TARAZI | — |
| JONATHAN TOWERS | — |
| ANDREW USYK | — |
Veterans VET
Issues related to the PACT Act Veteran's care and conditions related to toxic exposures and diseases.
Foreign entity interest: Ferring Holdings SA and Ferring BV listed on the registration under foreign entities have an interest in health equity.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN TOWERS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.